| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 Oct 2026 | 26 Oct 2026 |
| Quarterly Results. Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 & 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company will be held on Friday, October 30, 2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year Ended 30th September, 2026. Further to our earlier intimation given on September 26-09-2026 and as per the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window shall remain closed for Directors, Designated Persons and their immediate relatives from the end of the Quarter till Sunday, November 01, 2026 i.e. till the completion of 48 hours after the declaration Financial Results at the Board Meeting and shall re-open from Monday, November 02, 2026. OUTCOME OF THE BOARD MEETING HELD ON 30TH OCTOBER 2026 to Consider and approve the Unaudited Financial Results along with Limited Review Report for the quarter and six months ended 30thSeptember 2026 (Unaudited Financial Results and other business as attached (As per BSE announcement dated on : 30.10.2026) | ||
| Board Meeting | 31 Aug 2026 | 24 Aug 2026 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 inter alia to consider and approve (i)discussion and consideration of proposal for raising further capital as details attached (ii) Increase in the Authorized Share Capital of the Company and Consequential Alteration of the Capital Clause (Clause V) of the Memorandum of Association and any other business (iii) Any other matter with permission of the Chair Outcome of the Board Meeting held on 31st August, 2026 (As Per BSE Announcement Dated on: 31/08/2026) | ||
| Board Meeting | 13 Aug 2026 | 10 Aug 2026 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Pursuance to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we here inform you that a meeting of the Board of Directors of Wardwizard Healthcare Limited (Formerly known as Ayoki Mercantile Limited) (the Company) is scheduled to be held on Thursday August 13 2026 inter-alia to consider/approve the following matters: (i) Approval of Un-audited Standalone Financial Results of the Company for the First quarter ended 30th June 2026 for the financial year 2026-27. (ii) Any other business as the Board deemed fit to discuss with the permission of the chair and majority of directors present in the meeting. Attached herewith the Unaudited Financial Results for the First Quarter ended 30th June 2026 (As Per BSE Announcement Dated on 13.08.2026) | ||
| Board Meeting | 16 Jul 2026 | 16 Jul 2026 |
| Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has appointed Statutory Auditor of the Company on the Board meeting Held on 16th July 2026 and approve the new website of the Company. Details is Attached for you reference and record. | ||
| Board Meeting | 30 May 2026 | 26 May 2026 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve (i) The Audited Standalone Financial Results of the Company for the Fourth quarter (Q4) and year ended March 31 2026 along with the Audited Report. (ii) for raising of funds by way of the issue of equity shares convertible securities and / or any other eligible securities on a rights / preferential basis or any other permissible mode / and / or combination thereof as may be considered appropriate subject to all such regulatory/statutory approvals as may be required including the approval of shareholders of the Company. (iii) Any other matter as may necessary for the proposed issue of raising of fund. (iv) Appointment of Chief Financial Officer of the Company. (v) Any other business as the Board deemed fit to discuss with the permission of the chairperson and majority of directors present in the meeting. Pursuant to Regulation 30, 33 and schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at its meeting held today, i.e. Saturday,30th May,2026, inter alia have transacted, discussed, approved, and taken on record the following matters attached herewith. (As Per BSE Announcement Dated On : 30.05.2026) | ||
| Board Meeting | 23 Mar 2026 | 19 Mar 2026 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/03/2026 inter alia to consider and approve Wardwizard Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/03/2026inter alia to consider and approve Enclosed herewith Board Meeting Intimation Outcome of Meeting of Board of Directors of the Company held on 23rd March 2026 is herewith attached for your reference. (As per BSE Announcement dated on: 23.03.2026) | ||
| Board Meeting | 12 Feb 2026 | 9 Feb 2026 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Pursuance to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we hereby inform you that a meeting of the Board of Directors of Wardwizard Healthcare Limited (Formerly known as Ayoki Mercantile Limited) (the Company) is scheduled to be held on Thursday February 12 2026 inter-alia to consider/approve the following matters: (i) Approval of Un-audited Standalone Financial Results of the Company for the third quarter and nine month ended 31st December 2025 for the financial year 2025-26. (ii) Any other business as the Board deemed fit to discuss with the permission of the chair and majority of directors present in the meeting. Pursuant to Regulation 30, 33 and schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at its meeting held today, i.e Thursday, 12th February, 2026, inter alia have transacted, discussed, approved, and taken on record the following matters as attached herewith. The Board meeting commenced at 04:00 P.M.(IST) and discussions on the above agenda items concluded at 05:55 P.M. (IST). Attached herewith Unaudited financial Results for the third Quarter and nine month ended 31st December 2025 (As Per BSE Announcement Dated on:12.02.2026) | ||
| Board Meeting | 14 Nov 2025 | 11 Nov 2025 |
| Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Pursuance to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we hereby inform you that a meeting of the Board of Directors of Wardwizard Healthcare Limited (Formerly known as Ayoki Mercantile Limited) (the Company) is scheduled to be held on Friday November 14 2025 inter-alia to consider/approve the following matters: (i) Approval of Un-audited Standalone Financial Results of the Company for the second quarter and half yearly ended 30th September 2025 for the financial year 2025-26. (ii) To Consider and Approve the appointment of Chief Executive Officer of the Company. (iii) To Re-constitution of the Stakeholder Relationship Committee (iv) Any other business as the Board deemed fit to discuss with the permission of the chair and majority of directors present in the meeting. Pursuant to Regulation 30, 33 and schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at its meeting held today, i.e Friday, 14th November, 2025, inter alia have transacted, discussed, approved, and taken on record the following matters attached herewith (As Per BSE Announcement Dated on:14.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
